Breaking News Instant updates and real-time market news.

MDXG

MiMedx

$7.12

-0.15 (-2.06%)

17:53
03/15/18
03/15
17:53
03/15/18
17:53

Piper suspends MiMedx rating, says DOJ review too much to digest

Piper Jaffray analyst Matt O'Brien suspended his rating and price target on MiMedx Group after the company disclosed that the Department of Justice is reviewing matters in parallel with an SEC investigation. The analyst, up until tonight, had an Overweight rating on MiMedx with an $18 price target. The stock closed the trading day down 15c to $7.12. "We have been standing by MiMedx in recent months despite numerous short selling reports on the company," O'Brien tells investors in a research note. He says, however, that the Department of Justice review, which is added to an Audit Committee and SEC investigation regarding the company's sales and distribution practices, is "simply too much for us to digest at the moment."

  • 05

    Apr

  • 29

    May

MDXG MiMedx
$7.12

-0.15 (-2.06%)

02/23/18
CHLM
02/23/18
NO CHANGE
Target $19
CHLM
Buy
MiMedx fundamentals, execution should ultimately 'win out,' says Craig-Hallum
Craig-Hallum analyst Matt Hewitt noted that MiMedx management hosted an update call to address investor concerns about the recently announced investigation into sales practices and accounting, during which they revealed that King & Spalding has been hired as an independent legal advisor and KPMG will provide forensic accounting services. Uncertainty surrounding the investigation and recent short seller attacks have pushed shares over 50% off of their highs, but Hewitt ultimately thinks the company's fundamentals and strong execution will "win out," making the stock "intriguing" at current levels, he tells investors. He keeps a Buy rating and $19 price target on MiMedx shares.
02/23/18
LSCM
02/23/18
DOWNGRADE
LSCM
Hold
MiMedx downgraded to Hold from Buy at Lake Street
02/23/18
02/23/18
DOWNGRADE
Target $9

Hold
MiMedx downgraded to Hold with $9 price target at Lake Street
As previously reported, Lake Street analyst Bruce Jackson downgraded MiMedx to Hold from Buy, stating that a resolution of the investigation into current and prior period sales and distribution practices is unlikely to be swift and the shares are unlikely to outperform until the investigation is resolved. If the investigation resolves favorably, the upside potential "would be significant and he would be an aggressive buyer of the stock, but for now Jackson cut his price target on MiMedx shares to $9 from $12.
02/27/18
CHLM
02/27/18
NO CHANGE
Target $19
CHLM
Buy
Craig-Hallum maintains Buy rating, $19 price target on MiMedx
Craig-Hallum analyst Matt Hewitt noted that MiMedx denied a report that it is under investigation by the Department of Justice, stating that it is not aware of any such investigation. While stating that "it is impossible to know for certain whether any nefarious activity has ever taken place at MiMedx," Hewitt points to several events over the past year that give him confidence in the integrity of the company's financials. If the company's financials are sound, he estimate that the stock is worth two and a half times the current price, added Hewitt, who keeps a Buy rating and $19 price target on MiMedx shares.

TODAY'S FREE FLY STORIES

ANTM

Anthem

$250.75

6.71 (2.75%)

06:03
04/24/19
04/24
06:03
04/24/19
06:03
Earnings
Anthem backs FY19 revenue view approximately $100B, consensus $100.5B »

FY19 operating revenue is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 30

    Apr

  • 07

    May

  • 15

    May

  • 29

    May

PII

Polaris Industries

$97.77

-1.155 (-1.17%)

06:02
04/24/19
04/24
06:02
04/24/19
06:02
Initiation
Polaris Industries initiated  »

Polaris Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

ANTM

Anthem

$250.75

6.71 (2.75%)

06:02
04/24/19
04/24
06:02
04/24/19
06:02
Earnings
Anthem raises FY19 adjusted EPS view to greater than $19.20, consensus $19.16 »

Prior view was adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 30

    Apr

  • 07

    May

  • 15

    May

  • 29

    May

PG

Procter & Gamble

$103.19

-2.85 (-2.69%)

06:02
04/24/19
04/24
06:02
04/24/19
06:02
Downgrade
Procter & Gamble rating change  »

Procter & Gamble…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDSO

Medidata

$87.62

-2.68 (-2.97%)

06:01
04/24/19
04/24
06:01
04/24/19
06:01
Downgrade
Medidata rating change  »

Medidata downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 23

    Jun

OC

Owens Corning

$55.60

1.24 (2.28%)

06:01
04/24/19
04/24
06:01
04/24/19
06:01
Earnings
Owens Corning reports Q1 adjusted EPS 54c, consensus 58c »

Reports Q1 revenue $1.7B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

ANTM

Anthem

$250.75

6.71 (2.75%)

06:00
04/24/19
04/24
06:00
04/24/19
06:00
Hot Stocks
Breaking Hot Stocks news story on Anthem »

Anthem raises FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 30

    Apr

  • 07

    May

  • 15

    May

  • 29

    May

ANTM

Anthem

$250.75

6.71 (2.75%)

06:00
04/24/19
04/24
06:00
04/24/19
06:00
Earnings
Anthem reports Q1 adjusted EPS $6.03, consensus $5.86 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 30

    Apr

  • 07

    May

  • 15

    May

  • 29

    May

TWTR

Twitter

$39.76

5.37 (15.62%)

05:57
04/24/19
04/24
05:57
04/24/19
05:57
Periodicals
Trump complained to Dorsey that Twitter removed some followers, WaPo says »

President Trump…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

NVS

Novartis

$75.84

0.42 (0.56%)

05:38
04/24/19
04/24
05:38
04/24/19
05:38
Earnings
Novartis raises FY19 core operating income view to high single-digit growth »

Expects FY19 revenue to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 28

    Apr

  • 04

    May

  • 08

    May

  • 22

    May

  • 31

    May

NVS

Novartis

$75.84

0.42 (0.56%)

05:36
04/24/19
04/24
05:36
04/24/19
05:36
Earnings
Novartis reports Q1 core EPS $1.21, consensus $1.20 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 28

    Apr

  • 04

    May

  • 08

    May

  • 22

    May

  • 31

    May

VBIV

VBI Vaccines

$2.00

0.05 (2.56%)

05:34
04/24/19
04/24
05:34
04/24/19
05:34
Conference/Events
VBI Vaccines to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

  • 23

    May

PLCE

Children's Place

$109.92

2.95 (2.76%)

05:34
04/24/19
04/24
05:34
04/24/19
05:34
Initiation
Children's Place initiated  »

Children's Place…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TAC

TransAlta

$6.88

-0.175 (-2.48%)

05:32
04/24/19
04/24
05:32
04/24/19
05:32
Hot Stocks
TransAlta comments on Mangrove Partners release, urges holders to vote BLUE card »

TransAlta commented on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

CRI

Carter's

$105.13

2.02 (1.96%)

05:31
04/24/19
04/24
05:31
04/24/19
05:31
Initiation
Carter's initiated  »

Carter's initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 16

    May

STRL

Sterling Construction

$13.77

0.19 (1.40%)

05:30
04/24/19
04/24
05:30
04/24/19
05:30
Hot Stocks
Sterling Construction awarded $23M contract by UDOT »

Sterling Construction…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 08

    May

COST

Costco

$245.56

2.1 (0.86%)

05:27
04/24/19
04/24
05:27
04/24/19
05:27
Recommendations
Costco analyst commentary at Baird »

Costco price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

  • 30

    May

EBAY

eBay

$36.66

0.51 (1.41%)

05:22
04/24/19
04/24
05:22
04/24/19
05:22
Recommendations
eBay analyst commentary  »

eBay price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABMD

Abiomed

$262.32

1.39 (0.53%)

05:19
04/24/19
04/24
05:19
04/24/19
05:19
Recommendations
Abiomed analyst commentary at Piper Jaffray »

CMS proposed rate changes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 05

    Jun

  • 13

    Nov

MMSI

Merit Medical

$59.13

1.57 (2.73%)

05:16
04/24/19
04/24
05:16
04/24/19
05:16
Recommendations
Merit Medical analyst commentary at Piper Jaffray »

Piper calls Merit Medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 08

    May

  • 23

    May

HOLX

Hologic

$44.26

1.26 (2.93%)

05:13
04/24/19
04/24
05:13
04/24/19
05:13
Recommendations
Hologic analyst commentary at Piper Jaffray »

Hologic checks suggest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 03

    May

  • 07

    May

  • 29

    May

  • 05

    Jun

SYK

Stryker

$186.95

4.905 (2.69%)

05:09
04/24/19
04/24
05:09
04/24/19
05:09
Recommendations
Stryker analyst commentary at Piper Jaffray »

Stryker's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 08

    May

  • 29

    May

ICLK

iClick Interactive Asia

$3.89

-0.115 (-2.87%)

05:08
04/24/19
04/24
05:08
04/24/19
05:08
Hot Stocks
iClick enters marketing technology joint venture with VGI »

VGI Global Media and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBAY

eBay

$36.66

0.51 (1.41%)

05:05
04/24/19
04/24
05:05
04/24/19
05:05
Recommendations
eBay analyst commentary at Piper Jaffray »

eBay price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOG

Harley-Davidson

$38.92

-0.79 (-1.99%)

05:03
04/24/19
04/24
05:03
04/24/19
05:03
Downgrade
Harley-Davidson rating change at Goldman Sachs »

Harley-Davidson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.